Epicore Biosystems
Cambridge, US · Founded 2017 · Delaware corporation · 4 known investors
Find your way into Epicore Biosystems
406 people in our graph share verified history with the Epicore Biosystems team — schools, employers, funds. One of them is your warm intro.
Aydin Senkutunlockedknows Alexander J. Aranyosi · together at Boston University (overlapped)
×3knows the team · via MIT
×5knows the team · via Massachusetts General Hospital
knows the team · via MC10 Inc.
×2knows the team · via Boston University
Founders & leadership
Epicore Biosystems was founded in 2017 by Roozbeh Ghaffari, John Rogers, and Alexander J. Aranyosi.
RG
Roozbeh GhaffariinCEO & co-Founder
JR
John RogersCo-founder
AJ
Alexander J. AranyosiinCo-founder · Chief Digital Officer and Senior Vice President of ResearchAlexander J. Aranyosi is an executive officer at Epicore Biosystems, which develops physiological and metabolic bio-sensing and bio-monitoring technologies.
SL
Stephen LeeinChief Technical Officer, Co-Founder
JR
James RyaninExecutive
JW
John WrightinChief Operating Officer, SVP Translational Research & Development
JM
Jeffrey ModelExecutive
WL
Weihua LiExecutive
Board
KQ
Kimberly QuerreyBoard director
LL
Laura LangBoard director
Investors · 4
Castor Ventures (an Alumni Ventures Fund)
Joyance PartnersBerlin
Pegasus Tech Venturesreported · 2 sourcesSan Jose
Also in the syndicate · 1
Steele Foundation for Hopelead
Reported raises · per SEC filings
Form D private placements$37.1M disclosed across 4 rounds · 2018–2024
▶$25.7MraisedApr 2025 · 4 investors · BiotechnologyRule 506(b)
▶$25.7MraisedApr 2025 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen LeeExecutive Officer
- James RyanExecutive Officer
- Kimberly QuerreyDirector
- John WrightExecutive Officer
- Jeffrey ModelExecutive Officer
- Roozbeh GhaffariExecutive Officer, Director
- John RogersDirector
- Alexander J. AranyosiExecutive Officer
- Weihua LiExecutive Officer
- Laura LangDirector
- Offering amount
- $35M
- Amount sold
- $25.7M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2024 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedFeb 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES RYANExecutive Officer
- JEFF MODELExecutive Officer
- JOHN ROGERSDirector
- STEPHEN LEEExecutive Officer
- JOHN WRIGHTExecutive Officer
- ROOZBEH GHAFFARIExecutive Officer, Director
- LAURA LANGDirector
- Offering amount
- $10M
- Amount sold
- $1.5M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9.5MraisedFeb 2022 · 5 investors · BiotechnologyRule 506(b)
▶$9.5MraisedFeb 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ROOZBEH GHAFFARIExecutive Officer, Director
- JOHN ROGERSDirector
- Offering amount
- $10M
- Amount sold
- $9.5M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$350KraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
▶$350KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John RogersExecutive Officer, Director
- Roozbeh GhaffariExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $350K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapRunner's24 shared keywordsRunner's World is a media and training resource for runners of all levels, providing content on running training, nutrition, gear reviews, and health guidance.
Nix17 shared keywordsNix develops wearable biosensors that measure health metrics like hydration in real-time for athletes, soldiers, and laborers outside traditional healthcare settings. The company's first product is a hydration biosensor designed to optimize safety and performance monitoring.
Flowbio14 shared keywordsFLOWBIO makes a wearable sweat sensor and companion app that continuously measure an athlete's fluid and sodium loss and turn the data into personalized hydration and rehydration plans. Aimed at athletes and performance centres, the system streams real-time data to devices like Wahoo, Garmin, COROS and Zwift and has been validated in a peer-reviewed study.
The Feed12 shared keywordsThe Feed is an online marketplace selling curated sports nutrition, supplements, recovery gear and wearables to endurance athletes.
Companies competing with Epicore Biosystems for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $299.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $251.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Epicore Biosystems?
- Epicore Biosystems was founded by Roozbeh Ghaffari, John Rogers, Alexander J. Aranyosi in 2017.
- Who are Epicore Biosystems's investors?
- Epicore Biosystems's investors include Castor Ventures (an Alumni Ventures Fund), Joyance Partners, Pegasus Tech Ventures.
- How much funding has Epicore Biosystems raised?
- Epicore Biosystems has disclosed $37.1M raised across 4 rounds.
- Where is Epicore Biosystems headquartered?
- Epicore Biosystems is headquartered in Cambridge, US.